{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:55:43Z","timestamp":1784868943015,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.hbpd.2023.08.004","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T15:50:37Z","timestamp":1691077837000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Chao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Boon-Bee","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Cheng","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah-Kheong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Kay","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Cheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2023.08.004_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.aohep.2019.07.013","article-title":"Chronic kidney disease in patients with non-alcoholic fatty liver disease: what the hepatologist should know?","volume":"19","author":"Kiapidou","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/1751-2980.12465","article-title":"Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up","volume":"18","author":"Zeng","year":"2017","journal-title":"J Dig Dis"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0004","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1007\/s12325-020-01385-z","article-title":"Troponin levels relate to CRP concentrations in patients with NAFLD on maintenance haemodialysis: a retrospective study","volume":"37","author":"Capone","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCG.0000000000001389","article-title":"Renal failure is associated with increased mortality and hospital utilization in patients admitted with nonalcoholic steatohepatitis","volume":"55","author":"Reja","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/liv.14274","article-title":"Liver fibrosis by FibroScan\u00ae independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes","volume":"40","author":"Lombardi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhep.2020.03.003","article-title":"Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease","volume":"73","author":"Zou","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0008","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinre.2019.02.004","article-title":"Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities","volume":"43","author":"\u00d6nnerhag","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/apt.14219","article-title":"Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD","volume":"46","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0011","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0012","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0014","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cgh.2022.06.013","article-title":"AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD","volume":"21","author":"Pennisi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MEG.0000000000001045","article-title":"Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA","volume":"30","author":"Wijarnpreecha","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biom12010105","article-title":"Liver stiffness, albuminuria and chronic kidney disease in patients with NAFLD: a systematic review and meta-analysis","volume":"12","author":"Ciardullo","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0018","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0019","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0020","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.2337\/dc22-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0022","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0024","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0026","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211048649","article-title":"The association between NAFLD and risk of chronic kidney disease: a cross-sectional study","volume":"12","author":"Cao","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms21010171","article-title":"FIB-4 index and diabetes mellitus are associated with chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease","volume":"21","author":"Seko","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0029","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12072-015-9690-5","article-title":"High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12876-020-01278-z","article-title":"Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between East and West?","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0031","doi-asserted-by":"crossref","first-page":"e3957","DOI":"10.1210\/clinem\/dgab425","article-title":"New nonalcoholic fatty liver disease and fibrosis progression associate with the risk of incident chronic kidney disease","volume":"106","author":"Zuo","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jfma.2019.07.007","article-title":"Higher NAFLD fibrosis score is associated with impaired eGFR","volume":"119","author":"Hsieh","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0033","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.diabet.2019.11.003","article-title":"Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD","volume":"46","author":"Sun","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0034","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jceh.2017.12.005","article-title":"Renal dysfunction in patients with nonalcoholic fatty liver disease is related to the presence of diabetes mellitus and severity of liver disease","volume":"9","author":"Nampoothiri","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.diabet.2019.11.004","article-title":"Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes","volume":"46","author":"Mantovani","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0036","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3489","article-title":"Serum creatinine levels and risk of nonalcohol fatty liver disease in a middle-aged and older Chinese population: a cross-sectional analysis","volume":"38","author":"Niu","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0039","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s13300-021-01011-3","article-title":"Empagliflozin improves liver steatosis and fibrosis in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial","volume":"12","author":"Chehrehgosha","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(23)00068-7","article-title":"Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial","author":"Loomba","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0041","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40620-020-00751-y","article-title":"Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease","volume":"34","author":"Kanbay","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0042","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41374-019-0239-4","article-title":"Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet","volume":"99","author":"Saito","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.hbpd.2023.08.004_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","author":"Tacke","year":"2023","journal-title":"J Hepatol"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T10:25:54Z","timestamp":1729160754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387223001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1499387223001236"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.08.004","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}